Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$10,495,013
+$1,205,336 QoQ
Shares Held
8,750
-13.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#1,235
of 4,605 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $45,805,043 across 9 Drug Manufacturers - General names. LLY ranks #1 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,750 | $10,495,013 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,500 | $7,390,890 | |
| 3 | JNJ |
Johnson & Johnson
|
28,200 | $7,161,954 | |
| 4 | AMGN |
Amgen Inc
|
16,400 | $5,938,768 | |
| 5 | ABBV |
AbbVie Inc.
|
21,200 | $5,334,768 | |
| 6 | PFE |
Pfizer Inc
|
166,450 | $4,008,116 | |
| 7 | MRK |
Merck & Co., Inc.
|
30,000 | $3,855,000 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,000 | $1,210,020 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,495,013 | 8,750 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $9,289,677 | 10,100 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $10,746,801 | 10,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $10,625,538 | 13,926 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $11,245,499 | 14,426 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $7,928,736 | 9,600 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $5,790,000 | 7,500 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $6,378,768 | 7,200 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $7,985,451 | 8,820 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $5,290,128 | 6,800 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $3,788,980 | 6,500 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $3,491,345 | 6,500 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $3,048,370 | 6,500 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $3,159,464 | 9,200 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $2,743,800 | 7,500 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $2,748,475 | 8,500 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $2,593,840 | 8,000 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $2,434,145 | 8,500 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $6,622,926 | 23,977 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $7,873,028 | 34,075 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $5,760,033 | 25,096 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||